PembrolizumabTransformed Sezary syndrome with tumours: case report

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-020-74315-6
中图分类号
学科分类号
摘要
引用
收藏
页码:192 / 192
相关论文
共 50 条
  • [22] Sezary syndrome without erythroderma: A case report and review of published work
    Kamijo, Hiroaki
    Miyagaki, Tomomitsu
    Norimatsu, Yuta
    Shishido-Takahashi, Naomi
    Kuzumi, Ai
    Asano, Yoshihide
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2019, 46 (01): : 61 - 64
  • [23] Sezary syndrome treated with extracorporeal photopheresis. Report of one case
    Molgo, Montserrat
    Jaque, Alejandra
    Vial, Veronica
    Ocqueteau, Mauricio
    Pereira, Jaime
    Chang, Mayling
    Gonzalez, Sergio
    REVISTA MEDICA DE CHILE, 2015, 143 (11) : 1449 - 1458
  • [24] A case of Sezary syndrome associated with hemophagocytosis
    Bader, Eanas
    Scarisbrick, Julia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB121 - AB121
  • [25] Folliculotropic mycosis fungoides (stage IIA) progressing to Sezary syndrome: a case report
    Agar, N.
    Whittaker, S. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (05) : 1197 - 1199
  • [26] A case of pre-Sezary syndrome
    Böhm, I
    Schupp, G
    Pakos, E
    Bauer, R
    INTERNIST, 1999, 40 (09): : 974 - 977
  • [27] TREATMENT BY LEUKOAPHERESIS IN A CASE OF SEZARY SYNDROME
    DIGUGLIELMO, R
    AVANZI, G
    LOMBARDO, R
    MILIANI, A
    COZZOLINQ, F
    VERCELLI, D
    HAEMATOLOGICA, 1982, 67 (03) : 480 - 481
  • [28] CYTOGENETIC FINDINGS IN A CASE OF SEZARY SYNDROME
    SCHMIDT, M
    STOLZMANN, WM
    NEUMANN, E
    CANCER GENETICS AND CYTOGENETICS, 1985, 16 (02) : 117 - 121
  • [29] PRE-SEZARY ERYTHRODERMA EVOLVING TO SEZARY SYNDROME - A REPORT OF 7 CASES
    BUECHNER, SA
    WINKELMANN, RK
    ARCHIVES OF DERMATOLOGY, 1983, 119 (04) : 285 - 291
  • [30] Brentuximab-induced splinter nail haemorrhages in a patient with Sezary syndrome: A case report
    Filipovic, Nika
    Likic, Robert
    Bulat, Vedrana
    Gasparov, Slavko
    Azdajic, Marija Delas
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (08) : 3883 - 3886